European Journal of Surgical Oncology
Volume 33 , Pages S84-S87 , December 2007

Treatment of advanced colorectal cancer in the elderly

  • C. Bruce

      Affiliations

    • Mersey Deanery, Liverpool, UK
    • ,
  • C.-H. Köhne

      Affiliations

    • Klinik für Onkologie/Hämatologie, Klinikum Oldenburg, Dr.-Eden-Str. 10, 26133 Oldenburg, Germany
    • ,
  • R.A. Audisio

      Affiliations

    • University of Liverpool, Whiston Hospital, Prescot L35 5DR, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 151430 1079.

,Accepted 26 September 2007.

References 

  1. Rosati G. Elderly patients with advanced colorectal cancer: which therapy is the safest?. Expert Opin Drug Saf. 2005 Nov;4(6):1041–1049
  2. Gallego R, Sanchez N, Maurel J. Chemotherapy for elderly patients with advanced colorectal carcinoma. Expert Rev Anticancer Ther. 2006 May;6(5):795–800
  3. Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383–1389
  4. D'Andre S, Sargent DJ, Cha SS, et al. 5-fluorouracil-based chemotherapy for advanced colorectal cancer in elderly patients: a North Central Cancer Treatment Group study. Clin Colorectal Cancer. 2005;4:325–331
  5. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomised GERCOR study. J Clin Oncol. 2004;22:229–237
  6. Köhne CH, van Cutsem E, Wils J, et al. Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European organisation for research and treatment of Cancer Gastrointestinal Group study 40986. J Clin Oncol. 2005;23:4856–4865
  7. Grothey A, Sargent D, Goldberg RM, et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004;18:136–147
  8. Goldberg R. Advances in the treatment of metastatic colorectal cancer. Oncologist. 2005;l0(Suppl. 3):40–48
  9. Berardi R, Saladino T, Mari D, et al. Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy. Tumori. 2005 Nov–Dec;91(6):463–466
  10. Folprecht G, Lutz MP, Schoffski P, et al. Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth facto receptor expressing metastatic colorectal carcinoma. Ann Oncol. 2006;17:450–456
  11. Chau I, Norman AR, Cunningham D, et al. Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal caner derive similar benefit without excessive toxicity when treatment with irinotecan monotherapy. Br J Cancer. 2004;91:1453–1458
  12. Camptosar® (irinotecan hydrochloride injection) prescribing information. Revised. Pharmacia & Upjohn Co; 2006 June;
  13. Tabah-Fisch I, Maindrault-Goebel F, Benavides M, et al. Oxaliplatin/%FU/LV is feasible, safe and active in elderly colorectal cancer (CRC) patients. ASCO; 2002 [abstract no. 556].
  14. Feliu J, Salud A. Escudero et al. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. Br J Cancer. 2006 April 10;94(7):969–975
  15. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol. 2006 September 1;24(25):4085–4091
  16. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–2947
  17. van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol. 2001;19:4097–4106
  18. Jensen SA, Longborn JT, Sorensen JV. Benefits and risks of palliative capecitabine based therapy to elderly patients with advanced colorectal cancer: Danish single centre experience. Acta Oncol. 2006;45:67–76
  19. Ho C, Ng K, O'Reilly S, Gill S. Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis. Clin Colorectal Cancer. 2005 Nov;5(4):279–282
  20. Avastin prescribing information. Available at: San Fransisco, California: Genentech; 2004;http://www.gene.com/gene/products/information/oncology/avastin/insert.jsp
  21. Nagano Y, Nojiri K, Matsuo K, et al. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg. 2005 Oct;201(4):511–516
  22. Pavlidis TE, Marakis G, Ballas K, et al. Safety of bowel resection for colorectal surgical emergency in the elderly. Colorectal Dis. 2006 Oct;8(8):657–662
  23. Tilney HS, Lovegrove RE, Purkayastha S, et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc. 2007 Feb;21(2):225–233
  24. Davies RJ, D'Sa IB, Lucarotti ME, et al. Bowel function following insertion of self-expanding metallic stents for palliation of colorectal cancer. Colorectal Dis. 2005 May;7(3):251–253
  25. Hunerbein M, Krause M, Noesta KT, et al. Palliation of malignant rectal obstruction with self-expanding metal stents. Surgery. 2005 Jan;137(1):42–47

PII: S0748-7983(07)00545-8

doi: 10.1016/j.ejso.2007.09.015

European Journal of Surgical Oncology
Volume 33 , Pages S84-S87 , December 2007

Article Tools